QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Joiakim, A. Articles by Reiners, J. J. Search for Related Content PubMed PubMed Citation Articles by Joiakim, A. Articles by Reiners, J. J., Jr.

SHORT COMMUNICATION

THE JUN N-TERMINAL KINASE INHIBITOR SP600125 IS A LIGAND AND ANTAGONIST OF THE ARYL HYDROCARBON RECEPTOR

Institute of Environmental Health Sciences (A.J., P.A.M., J.J.R.) Wayne State University Detroit, Michigan and Department of Environmental Medicine (C.P., T.A.G.) University of Rochester Rochester, New York

Exposure of the immortalized human breast epithelial cell line MCF10A to the Jun N-terminal kinase (JNK) inhibitor anthra[1,9-cd]pyrazol-6(2H)-one (SP600125) suppressed, in a concentration-dependent manner (IC₅₀ 2 µM), the induction of CYP1A1 by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Cotreatment with SP600125 also suppressed the accumulation of TCDD-induced nuclear aryl hydrocarbon receptor (AhR)-DNA complexes, as assessed by electrophoretic mobility shift assays. Concentrations of SP600125 50 µM did not transform the AhR into a DNA-binding species when added to rat liver cytosol. However, addition of SP600125 to cytosol just before TCDD addition completely suppressed AhR transformation and DNA binding (IC₅₀ 7 µM). Sucrose gradient analyses using rat liver and murine hepatoma 1c1c7 extracts demonstrated that SP600125 competed with TCDD for binding to the AhR. These results suggest that SP600125 is an AhR ligand and functions as an AhR antagonist at concentrations used to pharmacologically inhibit JNK.

This article has been cited by other articles:

				A. Braeuning and A. Buchmann The Glycogen Synthase Kinase Inhibitor 3-(2,4-Dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione (SB216763) Is a Partial Agonist of the Aryl Hydrocarbon Receptor Drug Metab. Dispos., August 1, 2009; 37(8): 1576 - 1580. [Abstract] [Full Text] [PDF]

				P. Monteiro, D. Gilot, S. Langouet, and O. Fardel Activation of the Aryl Hydrocarbon Receptor by the Calcium/Calmodulin-Dependent Protein Kinase Kinase Inhibitor 7-Oxo-7H-benzimidazo[2,1-a]benz[de]isoquinoline-3-carboxylic Acid (STO-609) Drug Metab. Dispos., December 1, 2008; 36(12): 2556 - 2563. [Abstract] [Full Text] [PDF]

				Wenjing Zhong, Yufen Xie, Yingchun Wang, J. Lewis, A. Trostinskaia, Fangfei Wang, E. E. Puscheck, and D. A. Rappolee Use of Hyperosmolar Stress to Measure Stress-Activated Protein Kinase Activation and Function in Human HTR Cells and Mouse Trophoblast Stem Cells Reproductive Sciences, September 1, 2007; 14(6): 534 - 547. [Abstract] [PDF]

				C. LaRosa and S. M. Downs Meiotic Induction by Heat Stress in Mouse Oocytes: Involvement of AMP-Activated Protein Kinase and MAPK Family Members Biol Reprod, March 1, 2007; 76(3): 476 - 486. [Abstract] [Full Text] [PDF]

				Y. Xie, E.E. Puscheck, and D.A. Rappolee Effects of SAPK/JNK inhibitors on preimplantation mouse embryo development are influenced greatly by the amount of stress induced by the media Mol. Hum. Reprod., April 1, 2006; 12(4): 217 - 224. [Abstract] [Full Text] [PDF]

				S. Chen, T. Operana, J. Bonzo, N. Nguyen, and R. H. Tukey ERK Kinase Inhibition Stabilizes the Aryl Hydrocarbon Receptor: IMPLICATIONS FOR TRANSCRIPTIONAL ACTIVATION AND PROTEIN DEGRADATION J. Biol. Chem., February 11, 2005; 280(6): 4350 - 4359. [Abstract] [Full Text] [PDF]

				Z. Tan, M. Huang, A. Puga, and Y. Xia A Critical Role For MAP Kinases in the Control of Ah Receptor Complex Activity Toxicol. Sci., November 1, 2004; 82(1): 80 - 87. [Abstract] [Full Text] [PDF]